Clinical Trial Update: Study of Nicotine for the Prevention of PONV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nicotine for the prevention of postoperative nausea and vomiting was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Postoperative Nausea and Vomiting | Phase 2 | Status: TERMINATED